. Effect of regional hyperemia on myocardial uptake of 2-deoxy-2-[ 18 F]fluoro-D-glucose. Am. J. Physiol. Endocrinol. Metab. 278: E96-E102, 2000.-2-Deoxy-2-[ 18 F]fluoro-D-glucose (FDG) may be used to predict glucose kinetics when the factor relating differences in transport and phosphorylation between compounds remains constant (''lumped constant''). It is not clear whether hyperemia alters that factor. In anesthetized swine, myocardial FDG uptake was estimated by positron emission tomography, during an intracoronary infusion of either adenosine, ATP, or bradykinin (40 µg · kg Ϫ1 · min Ϫ1 , 40 µg·kg Ϫ1 · min Ϫ1 , and 2 nmol · kg Ϫ1 · min Ϫ1 , respectively; n ϭ 6 for all groups). In controls during normal perfusion (n ϭ 6), FDG uptake was 0.78 Ϯ 0.32 µmol · g Ϫ1 · min Ϫ1 , whereas glucose uptake by Fick was 0.71 Ϯ 0.25 µmol · g Ϫ1 · min Ϫ1 (r ϭ 0.73; P Ͻ 0.05). Adenosine increased blood flow from 1.29 Ϯ 0.43 to 4.80 Ϯ 2.19 ml · g Ϫ1 · min Ϫ1 (P Ͻ 0.05) and glucose uptake from 1.16 Ϯ 1.10 to 3.35 Ϯ 2.12 µmol · g Ϫ1 · min Ϫ1 (P Ͻ 0.05), whereas FDG uptake in the hyperemic region was lower than remote regions (0.46 Ϯ 0.29 and 0.95 Ϯ 0.55 µmol · g Ϫ1 · min Ϫ1 , respectively; P Ͻ 0.05). In the ATP and bradykinin groups, blood flow increased four-and twofold, respectively, with no net change in glucose uptake. FDG uptake in the hyperemic region was also significantly lower than remote regions. For all animals, the ratio of blood flow in the hyperemic region relative to remote region was inversely proportional to the ratio of FDG uptake in the same regions (r 2 ϭ0.73; P Ͻ 0.001). Because nitric oxide elaboration during hyperemia could potentially alter substrate preference and FDG kinetics, six additional swine were studied during maximal adenosine before and after intracoronary N G -monomethyl-L-arginine (1.5 mg/kg). Inhibition of nitric oxide had no effect on either regional myocardial substrate uptake or FDG accumulation. In conclusion, hyperemia decreased regional myocardial FDG uptake relative to normally perfused regions and this effect on the lumped constant was independent of nitric oxide. positron emission tomography; swine; glucose metabolism; adenosine; vasodilatation; nitric oxide REGIONAL MYOCARDIAL GLUCOSE uptake can be quantitated in vivo with dynamic scanning with positron emission tomography (PET) and the glucose analog 2-deoxy-2-[ 18 F]fluoro-D-glucose (FDG). The accuracy of this technique assumes that the factor relating differences in transport and phosphorylation between molecules of glucose and FDG (i.e., ''lumped constant'') remains fixed (23). Although 0.67 has been traditionally used for the lumped constant with in vivo heart studies (2, 16, 18), results from isolated rat heart experiments have shown that the factor may vary under certain conditions such as during altered substrate and hormone levels (6). Therefore, the interpretation of absolute glucose measurements from FDG kinetic studies may be confounded when competing substrates in the blood are altered.
REGIONAL MYOCARDIAL GLUCOSE uptake can be quantitated in vivo with dynamic scanning with positron emission tomography (PET) and the glucose analog 2-deoxy-2-[ 18 F]fluoro-D-glucose (FDG). The accuracy of this technique assumes that the factor relating differences in transport and phosphorylation between molecules of glucose and FDG (i.e., ''lumped constant'') remains fixed (23) . Although 0.67 has been traditionally used for the lumped constant with in vivo heart studies (2, 16, 18) , results from isolated rat heart experiments have shown that the factor may vary under certain conditions such as during altered substrate and hormone levels (6) . Therefore, the interpretation of absolute glucose measurements from FDG kinetic studies may be confounded when competing substrates in the blood are altered.
Despite the inconstancy of the lumped constant during these variable metabolic conditions, the assessment of relative differences in regional myocardial FDG uptake for clinical decisions remains valid (24, 25) . Although patients with diabetes mellitus could have variable insulin levels, which, in turn, could affect the lumped constant (6) , that would not cause regional heterogeneity in myocardial FDG uptake. Thus far no clinical situation, including ischemia and reperfusion, has been shown to affect regional differences in the lumped constant (21) . In isolated rabbit septa, however, a fourfold increase in perfusion induced a 50% reduction in the value of the lumped constant when compared with Fick measurements of glucose uptake (8) . This would mean that during hyperemia, FDG kinetic studies would underestimate overall glucose uptake by ϳ50%. Whether the same degree of heterogeneity in myocardial perfusion can alter the lumped constant in vivo is not clear. The purpose of this study, therefore, was to determine the effects of hyperemia on regional glucose uptake by Fick and compare those results with FDG uptake by dynamic PET scanning. Adenosine, ATP, and bradykinin were used as the vasodilators because significant vasodilation is achievable with minimal effects on remote myocardium. A second aim was to determine whether nitric oxide elaborated during hyperemia could be responsible for a shift in substrate preference and altered FDG kinetics relative to glucose.
METHODS
Surgical preparation. This study was performed under the guidance of the Animal Care Committee at the Veterans Affairs Medical Center, which conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1985) . Domestic swine of either sex (31-42 kg) were
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. sedated with ketamine hydrochloride (20 mg/kg im) and thiopental (10 mg/kg iv). They were intubated and connected to a respirator for intermittent positive pressure ventilation with a mixture of oxygen and room air. Ventilator settings were adjusted during the experiments to maintain normal arterial pH (7.35-7.45), PCO 2 (35-45 mmHg), and PO 2 (Ͼ100 mmHg). The left external jugular vein, internal carotid artery, and femoral artery were exposed and cannulated with 7-Fr catheters.
Anesthesia was initiated with ␣-chloralose (150 mg/kg iv) and maintained with a continuous infusion of thiopental (5 mg·kg Ϫ1 ·h Ϫ1 ). Succinylcholine (0.25 mg iv) was administered, and via midline sternotomy, the heart was suspended in a pericardial cradle. A 7-Fr catheter was secured in the left atrium and used for administration of radiolabeled microspheres. A 5-Fr Millar catheter was inserted into the left ventricle (LV) through the apex and used for measurement of LV pressure and its first derivative (LV dP/dt). A proximal portion of the left anterior descending coronary artery (LAD) was dissected free from its adventitia and cannulated with a small silicone catheter (0.3 mm in inner diameter and 0.6 mm in outer diameter) (15) . A 22-Fr intracatheter was then inserted into the great cardiac LAD vein distal to the arterial infusion catheter. We have shown that during this anesthesia, systemic hemodynamics, regional shortening, and myocardial oxygen consumption are not altered over the time course of the scanning protocol.
Regional myocardial blood flow. One to two million microspheres (15 µ) labeled with either 141 Ce, 113 Sn, 103 Ru, or 95 Nb were injected into the left atrium for myocardial blood flow determination. Reference arterial blood samples were withdrawn from the femoral artery catheter at a fixed rate of 10 ml/min, beginning 5 s before and for 2 min after injection of microspheres. At the conclusion of the experiment and before death, myocardium in the LAD distribution was identified by injection of blue dye into the coronary artery catheter. Hearts were fixed in 10% Formalin for at least 48 h and separated into LAD and non-LAD regions. Each was then divided into three layers of equal thickness (inner, mid, and outer) and placed in 1-to 2-g samples. Myocardial and reference blood samples were counted in a multichannel analyzer (Gamma Counter-5000; Packard Instrument), and regional blood flows were determined.
Chemical analyses. Blood gas analyses were calculated from a pH analyzer (CIBA Corning model 178) and a Triac centrifuge (Clay Adams). Lactate and glucose concentrations were determined from aliquots of 3 ml of blood that were transferred into iced-glass tubes for later analysis by enzymatic technique. Free fatty acids were determined by standard RIA kits (Sigma). The extraction of substrates was calculated by plasma arteriovenous differences expressed as a percentage of plasma arterial concentrations, and Fick estimates of consumption were computed from the product of myocardial blood flows and the arteriovenous plasma differences.
Experimental protocol. During the animal preparation and ϳ1 h before the experimental protocol, 25 g of dextrose were infused intravenously in all animals. After a 30-min stabilization period, radiolabeled microspheres were injected and whole blood samples were collected from the aorta and great cardiac LAD vein. An intracoronary infusion of either adenosine (40 µg · kg Ϫ1 · min Ϫ1 ; n ϭ 6), ATP (40 µg · kg Ϫ1 · min Ϫ1 ; n ϭ 6), or bradykinin (2 nmol kg Ϫ1 · min Ϫ1 ) was begun for 10 min, and samples were repeated. Vasodilating agents were supplied from Sigma (St. Louis, MO) and were mixed on the morning of each experiment. For comparison, six control animals were subjected to the same instrumentation, and glucose uptake and FDG kinetics were determined during an intracoronary infusion of saline (2 cc/min). Blood flow and arteriovenous sampling were repeated at the conclusion of the PET scanning protocol.
In six swine, the effect of adenosine on regional substrate uptake was determined before and after inhibition of nitric oxide with intracoronary N G -monomethyl-L-arginine (1.5 mg/kg over 10 min). This agent was chosen for these studies because at this dose it has a significant effect on blunting nitric oxide production without altering maximal adenosine blood flow (7) . FDG kinetics with PET was then studied in two of those animals during an intracoronary infusion of adenosine. In two additional swine, FDG uptake was determined 50 min after a 10-min infusion of adenosine, to ensure that any altered FDG kinetics was not related to adenosine receptor stimulation independent of blood flow changes.
PET scanning procedures. Animals were moved into the scanning room where dynamic PET images were obtained with an ECAT 953B/31 (CTI/Siemens, Knoxville, TN). The camera consists of 16 contiguous rings of bismuth germinate detectors allowing acquisition of 31 cross-sectional images of the heart simultaneously recorded in a 10.8-cm axial field of view. In a transaxial plane, a resolution of 5.8 mm full width at half maximum would be expected at the center of the field of view. Emission images were reconstructed with a Hanning filter with a cutoff frequency of 0.4 of maximum (0-0.5 scale). The effective transaxial resolution of the reconstructed images is 10 mm. The animal preparations were placed onto the table, and with the use of a laser light detector, they were positioned so that the heart was in the center of the field of view. Measurement of attenuation due to tissue density was accomplished by a 10-min transmission scan with an internal source of radiation. After the transmission scan, myocardial blood flow images were obtained with either 15 O-water (40 mCi) or 13 N-ammonia (15 mCi) during the constant infusion of the vasodilator. These perfusion images were collected to confirm that regions of interest were placed in the hyperemic LAD territory. After five half-lives of the blood flow tracer, the intracoronary infusion was restarted and FDG (6 mCi) was infused intravenously over 20 s. Dynamic scans were acquired over the next 40 min with a scanning protocol consisting of twelve 10-s, six 30-s, four 60-s, three 120-s, and three 300-s frames and one 600-s frame.
Data analysis. Circular regions of interest (ROI) were chosen from ϳ10-12 transverse planes from the myocardial blood flow image. Eight-to-ten ROI were obtained from the hyperemic LAD region, and an equivalent number were also obtained from the normally perfused remote territory. A circular ROI was also obtained from the largest portion of the LV cavity (input function). FDG uptake was determined from Patlak plots of the time-activity curves obtained from the LV and each myocardial ROI. Values were averaged for LAD and non-LAD regions. The model has been previously described and validated and is based on a three-compartment model. In brief, the Patlak plot defines a constant (K), which incorporates the forward (k 1 ) and reverse (k 2 ) rate constants from plasma to tissue as well as the phosphorylation (k 3 ) constant. The formula is expressed as:
The dephosphorylation constant (k 4 ) is assumed to be zero. The model includes a spillover correction and has been previously validated in our laboratory (14) . Partial volume effects were corrected by assuming that 100% recovery would be expected in objects Ն15 mm and that the average myocardial wall thickness was 10 mm.
Statistics. Results are expressed as means Ϯ SD. For repeated measures, changes were tested for significance at the P Ͻ 0.05 level by paired Student's t-test. During the intracoronary infusions, a comparison was made between FDG uptake in the LAD region normalized to remote regions vs. myocardial blood flow by microspheres in the LAD region, normalized to remote regions. The relationship was tested for all experimental groups with a linear regression model.
RESULTS

Systemic hemodynamics and myocardial blood flows.
Systemic hemodynamics are shown for each group in Table 1 . Myocardial blood flows in the LAD and non-LAD regions of the control group were 0.84 Ϯ 0.22 and 0.92 Ϯ 0.22 ml · g Ϫ1 · min Ϫ1 , respectively. These were slightly lower than baseline blood flows in the adenosine group, which probably reflect the intergroup differences in heart rate and blood pressure. In the adenosine and ATP groups, myocardial blood flow in the LAD region increased nearly fourfold, whereas the increment in the bradykinin group was about twofold.
Plasma substrates and myocardial glucose uptake. Plasma substrates are shown in Table 1 . In the control group, myocardial glucose uptake by Fick analysis was 0.71 Ϯ 0.25 µmol · g Ϫ1 · min Ϫ1 (Fig. 1) . In the adenosine group, myocardial glucose uptake by Fick increased from 1.16 Ϯ 1.10 at baseline to 3.35 Ϯ 2.12 µmol · g Ϫ1 · min Ϫ1 (P Ͻ 0.05) without a net change in lactate uptake (0.51 Ϯ 0.10 at baseline vs. 0.37 Ϯ 0.08 µmol · g Ϫ1 · min Ϫ1 during adenosine; nonsignificant). Myocardial glucose uptake in the ATP group was 0.50 Ϯ 0.53 at baseline and 0.68 Ϯ 0.55 µmol · g Ϫ1 · min Ϫ 1 during the infusion (nonsignificant), whereas in the bradykinin group, it was 0.41 Ϯ 0.49 at baseline and 0.77 Ϯ 0.56 µmol · kg Ϫ1 · min Ϫ1 during the infusion (nonsignificant). Except for the adenosine group, vasodilation with either ATP or bradykinin resulted in no net change in regional myocardial glucose uptake by Fick (Fig. 1) .
FDG uptake in LAD and remote regions. Myocardial glucose uptake as determined by FDG kinetics is shown for all four groups in Fig. 2 . In the control group, regional myocardial FDG uptake in the LAD region was 0.78 Ϯ 0.32 µmol · g Ϫ1 · min Ϫ1 , which correlated well with estimates of glucose uptake by Fick (r ϭ 0.73; P Ͻ 0.05). This demonstrates that tracer kinetics with FDG predict myocardial glucose uptake under steady-state conditions. As shown from Fig. 2 , minimal differences in FDG uptake between LAD and remote regions were noted in the control group. In the adenosine, ATP, and bradykinin groups, however, FDG uptake in the hyperemic LAD region was lower than in the non-LAD regions. The remote regions of each of the hyperemic groups were not significantly dissimilar from the control group. Figure 3 is a representative animal during vasodilation and demonstrates decreased FDG uptake in the hyperperfused LAD region. 6 Values are means Ϯ SD; n ϭ 6/group. HR, heart rate; MAP, mean arterial pressure; LAD, left anterior descending coronary artery. Blood flows were measured by radiolabeled microspheres. LAD region was identified by injecting methylene blue into coronary artery, and entire heart was then separated and counted in multiple 1-to 2-g samples. * P Ͻ 0.05 vs. baseline. Fig. 1 . Results of myocardial glucose uptake by Fick are demonstrated in control, adenosine, ATP, and bradykinin groups, both at baseline and during vasodilation. Glucose uptake increased in hyperemic left anterior descending coronary artery (LAD) region during adenosine but remained unchanged with other 2 agents. * P Ͻ 0.05 vs. vasodilation. 
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To ensure that adenosine receptor stimulation did not alter FDG kinetics independent of perfusion, myocardial FDG uptake was determined 50 min after a 10-min infusion of adenosine in two additional animals. After the adenosine infusion but during normal perfusion, the metabolic rate of FDG uptake in the LAD and remote regions was 0.26 Ϯ 0.11 and 0.28 Ϯ 0.14 µmol · g Ϫ1 · min Ϫ1 , respectively. This demonstrates that after the adenosine infusion homogeneous tracer uptake is observed and that a sustained regional alteration in the lumped constant does not occur.
For each of the animals in the four groups, the relative change in FDG uptake in the LAD region was then compared with the relative change in blood flow in the same regions during the infusions. Figure 4 shows the relationship between FDG uptake in the LAD region normalized to remote regions vs. myocardial blood flow with microspheres in the LAD region, normalized to the non-LAD territory. By linear regression, a significant relationship existed between the relative degree of hyperemia and relative decrease in FDG uptake [f(x) ϭ Ϫ1.155075E Ϫ1(x) ϩ 1.0008085E ϩ 0; SE ϭ 0.139; r 2 ϭ 0.73; P Ͻ 0.001].
Nitric oxide inhibition and the effects on substrate uptake. Regional arteriovenous extraction of substrates was determined at baseline and during maximal adenosine, both before and after inhibition of nitric oxide synthase. Under basal conditions, arterial glucose and lactate concentrations were 5.6 Ϯ 2.5 and 1.3 Ϯ 0.6 µmol/ml, respectively, whereas fatty acid concentrations were 309 Ϯ 166 nmol/ml. Arterial concentrations remained constant over the sampling period. As shown by Table 2 , the inhibition of NO production induced no differences in relative substrate uptake during vasodilation with adenosine. In two animals, FDG uptake was determined during the adenosine infusion in the presence of the NO inhibitor. The metabolic rate of FDG uptake in the hyperemic LAD region was 0.14 Ϯ 0.02 µmol · g Ϫ1 · min Ϫ1 and was much lower than the corresponding remote region (0.20 Ϯ 0.03 µmol · g Ϫ1 · min Ϫ1 ). That difference in metabolic rates of FDG uptake is similar to that observed in the animals without the inhibitor. The findings demonstrate that elaboration of nitric oxide during hyperemia is not responsible for the decreased FDG uptake in the hyperemic regions.
DISCUSSION
The principal finding of this study is that adenosine in maximal vasodilator doses increased Fick estimates of glucose uptake but lowered FDG retention when compared with remote myocardium. This disparity between PET and Fick estimates of glucose uptake resulted from an underestimation in PET-derived glucose measurements during supramaximal increments in perfusion. During an intracoronary infusion of either ATP or bradykinin, no changes were noted in Fick estimates of glucose uptake but FDG uptake was also lower than remote regions. These observations support the contention that maximal increments in regional blood flow alter the factor relating differences in transport and phosphorylation between molecules of FDG and glucose (i.e., lumped constant). Fig. 3 . FDG uptake during a constant intracoronary infusion of ATP (left) is compared with myocardial blood flow with 13 N-ammonia (right) acquired from same plane. For both images, the animal is lying on its right side and projections are directed toward the head. Of note, FDG uptake in hyperemic LAD region was lower than that of normally perfused remote regions. Fig. 4 . Myocardial blood flow (microspheres) in hyperemic LAD region relative to remote territories is plotted against FDG uptake in LAD region during hyperemia, relative to remote region. A significant inverse relationship exists between relative decrease in FDG uptake and increased blood flow during vasodilation. 
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Variability of the lumped constant. The Sokoloff model of deoxyglucose kinetics for predicting glucose uptake was adapted for the brain and is reliable when differences in transport and phosphorylation between the two molecules are constant (23) . This factor has been termed the lumped constant and is comprised of six individual components, defined by the after equation
where is the distribution volumes for deoxyglucose and glucose and is assumed to remain constant, relates glucose 6-phosphatase activity and is negligible in heart tissue, and K m and V m are the Michaelis constants for glucose and deoxyglucose (* m ). In perfused rat hearts, the rate of accumulation of analogs of deoxyglucose correlates well with changes in glucose metabolism during physiological interventions such as altered workload (26) . Validation studies in dogs have further demonstrated the constancy of the lumped constant in predicting glucose uptake under resting conditions (18) .
Recently, however, it has become apparent that FDG kinetic studies may have inherent limitations in predicting absolute measurements of glucose metabolism under various circumstances. In extracorporeally perfused pig hearts, the accumulation of 14 C-labeled deoxyglucose was insensitive to changes in glucose utilization as measured by 3 H-labeled glucose when overall glucose flux was low (12) . Likewise, changes in deoxyglucose levels may not predict large changes in glucose uptake if the lumped constant becomes altered, such as during variable substrate levels. In isolated rat hearts perfused with increasing concentrations of either insulin, fatty acids, or lactate, the lumped constant was lowered causing deoxyglucose kinetics to underestimate overall glucose uptake (6) . Although these studies are important for interpreting global estimates of myocardial glucose uptake, they are less relevant to clinical PET studies in which FDG uptake from one region is compared with remote territories (24, 25) .
Perfusion and the lumped constant. The present study identifies a situation in which FDG uptake within two regions of the same myocardium might not be comparable due to regional differences in the lumped constant. The fourfold difference in perfusion between LAD and non-LAD regions during the intracoronary infusion of adenosine was responsible for the observed decrease in the lumped constant. In isolated rat hearts, a twofold increase in myocardial blood flow did not alter the lumped constant during three levels of glucoseinsulin concentrations (17) , suggesting that FDG kinetic studies are unaffected by modest changes in blood flow. With larger changes in perfusion such as during maximal vasodilation, however, the reliability of FDG kinetic studies in estimating glucose uptake may be affected. For instance, in isolated perfused rabbit septa, a 50% reduction in the lumped constant occurred when perfusion was increased from 0.5 to 4.5 ml · g Ϫ1 · min Ϫ1 (8) . This resulted in a 50% underestimation in glucose uptake relative to Fick measures of glucose uptake. These data are compatible with the present findings in which the magnitude of the flow increment with adenosine was fourfold and the estimates of glucose uptake in the involved regions were ϳ50% less than that of remote territories. The effects of hyperemic flows on the lumped constant may relate to differential changes in the transport coefficient between molecules of FDG and glucose (K* 1 /K 1 ). In the rat brain, this transport coefficient for FDG was found to be 1.67, which implies that the transport carrier system favors FDG over glucose (3) . When transport exceeds phosphorylation rates, as occurs during hyperemic states, the lumped constant would be expected to approach the phosphorylation coefficient of FDG-glucose. Under those circumstances, a decreased lumped constant is observed.
Adenosine and glucose uptake. Adenosine regulates regional myocardial blood flow and, in addition, may play a critical role in modulating metabolism. In anesthetized dogs, an intracoronary adenosine infusion increased glucose uptake at least fourfold in the presence of insulin (10, 11) , which is consistent with the findings in the present study. Because the effects of adenosine on glucose uptake were minimal without insulin, the authors proposed a mechanism involving postinsulin receptors (10) . This is at variance with studies from normoxic rat hearts, however, which have shown that the effects on glucose uptake by adenosine and insulin are additive but via independent mechanisms (1). This also differs from studies of isolated rat hearts, which have shown that adenosine inhibits glucose metabolism, particularly when glucose is the sole substrate (4, 5) .
It is unlikely that the effects of adenosine on glucose uptake are flow mediated. Hyperemic flow responses with nitroprusside in both in vivo and in vitro preparations had minimal effects on glucose uptake, whereas similar increments in flow with adenosine caused substantial increases in glucose uptake (11, 13) . The magnitude of the change in glucose uptake in those in vivo studies is similar to the nearly fourfold increase in Fick measures of glucose uptake by adenosine observed in the present study. It is conceivable that exogenous adenosine could also alter the lumped constant by virtue of the insulin-like actions of A 1 -receptor stimulation (27) . Insulin has been shown to reduce the lumped constant in isolated rat hearts presumably by the migration of hexokinase from the cytoplasm to the mitochondria where it preferentially binds glucose over deoxyglucose (20) . Against this as the mechanism, however, is the observation that ATP and bradykinin also increased myocardial blood flow and like adenosine lowered FDG uptake within the hyperperfused regions. In two animals, we observed that during normal blood flows, myocardial FDG uptake was homogeneous after the hyperemic period. Therefore, it is unlikely that a transient infusion of adenosine could affect a persistent effect on FDG kinetics, independent of perfusion.
Although the vasodilators used in the present series involved both endothelium-dependent and -independent mechanisms, the elaboration of nitric oxide via endothelium-dependent flow-induced dilation could elaborate nitric oxide (9) and alter regional myocardial http://ajpendo.physiology.org/ substrate uptake (19) . In a separate group of animals, we determined regional myocardial substrate uptake during adenosine, both before and after inhibition of nitric oxide synthesis with N G -monomethyl-L-arginine. This dose has been shown to inhibit nitric oxide without affecting maximal adenosine flows (7) . The results showed that the effect of adenosine on regional myocardial substrate uptake or FDG kinetics was not altered by nitric oxide synthase inhibition. Therefore, the effects of hyperemia on the lumped constant are not a nonspecific effect of nitric oxide elaboration during maximal vasodilation.
Limitations. A limitation of the study is the use of Fick measures of glucose uptake to assess changes in glucose uptake. To accurately judge the limitations of FDG kinetics, alternate tracers such as [ 14 C]glucose and [ 13 C]lactate may provide more specific information about intermediate metabolites and be more sensitive, particularly during low rates of glucose consumption (22) .
In summary, quantitative PET measurements of regional FDG uptake may underestimate myocardial glucose uptake when perfusion is increased maximally. This effect seems independent of the agent used to induce maximal vasodilation and is consistent with the contention that supramaximal increases in myocardial blood flow alter the factor relating differences in transport and phosphorylation between molecules of glucose and deoxyglucose (lumped constant). Because the range of flow increments in the present study is far greater than might be encountered during clinical PET studies, it is doubtful that the results would alter the interpretation of FDG uptake within heterogeneously perfused myocardial regions in patients. However, future studies should address how modest changes in regional perfusion might alter FDG kinetics.
